Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Synopsys

Dow Jones Futures Rise After Many Market Rally Leaders Crack; Tesla China Sales Ramping Up

Dow Jones futures: Indexes held support Wednesday, but market rally leaders sold off. Tesla China sales rose in May, but still ramping up.

Investors Business Daily

Top Funds Bet On AI And Software Stock Driving 'Smart Everything'

As Synopsys drives smart technology and AI and machine learning innovations, the stock designs a new buy point.

Investors Business Daily

Here's How Much You Would Have Made Owning Synopsys Stock In The Last 10 Years

Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 15.2% on an annualized basis producing an average annual return of 27.35%. Currently, Synopsys has a market capitalization of $50.46 billion.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

2 Stocks to Buy After Raising Their Full Year Outlooks

Investors' concerns over the Federal Reserve's interest rate increases to combat inflationary pressures, and looming recession fears, have heightened market volatility. However, a few companies look sufficiently well positioned to withstand the current market turbulence and they recently raised their full-year outlooks. Therefore, we think it could be wise to…

StockNews.com

Oil Stocks Lead Charge Of Breakouts And Buy Zones In New Uptrend

With a new uptrend underway, oil stocks like TotalEnergies and tech stocks like Synopsys set the stage for new breakouts.

Investors Business Daily

Synopsys Stock Shows Rising Price Performance With Jump To 86 RS Rating

Synopsys shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 78 to 86.

Investors Business Daily

Synopsys: A High-Quality Growth Stock to Buy Now

Thanks to strategic partnerships and acquisitions, technology company Synopsys (SNPS) has achieved considerable operating-margin expansion across its business sectors. And given the company’s strong fundamentals and potential for long-term profitable growth, we think its stock is a great bet now. Read on.

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Design Software Leader Synopsys' Stock Earns Rating Upgrade

Synopsys stock shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 80 to 84.

Investors Business Daily

Synopsys Stock Gains After Q2 Results Tops Estimates, Raised FY22 Guidance

Synopsys, Inc. (NASDAQ: SNPS) reported secon

Benzinga

Recap: Synopsys Q2 Earnings

Synopsys (NASDAQ:SNPS) reported its Q2 earnings results on Wednesday, May 18, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Synopsys beat estimated earnings by 5.49%, reporting an EPS of $2.5 versus an estimate of $2.37.

Benzinga

Synopsys Surges After Topping Targets, Guiding Well Above Views

Synopsys, a maker of semiconductor design software, surged Thursday after it handily beat analyst estimates for its fiscal second quarter.

Investors Business Daily

Adobe vs. Synopsys: Which Growth Stock is a Better Buy?

Despite aggressive interest rate hikes expectations and other factors keeping the market volatile, the recovering labor market and substantial corporate profits have driven the performance of some quality growth stocks like Synopsys (SNPS) and Adobe (ADBE). But which of these two stocks is a better buy now? Read more to…

StockNews.com

Top-Ranked Synopsys Stock Moves Up A Notch

Synopsys shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Investors Business Daily

3 Beaten-Down Growth Stocks to Snatch Up in Q2 2022

Despite no clarity on when the Russia-Ukraine war will end, surging inflation, and logistical hindrances, the U.S. economy looks sufficiently resilient to weather the crises. Given this backdrop, we think shares of beaten-down growth stocks IQVIA (IQV), West Pharmaceutical (WST), and Synopsys (SNPS) could soar in price in the coming…

StockNews.com

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

IBD Screen Of The Day: Analysts Raise Profit Estimates On These Top Ranked Stocks

Semiconductor design and verification stock Synopsys has been displaying strong growth with a three-year EPS growth rate of 26%.

Investors Business Daily

Dow Jones Gains; Twitter Stock Explodes As Elon Musk Invests; Donald Trump SPAC Plummets

The Dow Jones gained. Twitter exploded on news Tesla CEO Elon Musk has bought shares. The Donald Trump SPAC plummeted.

Investors Business Daily

Synopsys Ranks No. 1 Among Software Makers

Synopsys sees its Relative Strength Rating move into the 80-plus level.

Benzinga

This Foreboding Sign Looms Over Synopsys's Chart

If history is any guide, there may be trouble ahead for shares of Synopsys (NASDAQ:SNPS). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Synopsys: Q1 Earnings Insights

Synopsys (NASDAQ:SNPS) reported its Q1 earnings results on Wednesday, February 16, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Synopsys beat estimated earnings by 1.27%, reporting an EPS of $2.4 versus an estimate of $2.37.

Benzinga

Synopsys Earnings Preview

Synopsys (NASDAQ:SNPS) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that Synopsys will report an earnings per share (EPS) of $2.37.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.